2 results
Approved WMOWill not start
The primary objective is to determine the pharmacokinetic characteristics of galantamine after 2 single oral doses in children with Down syndrome. Secondary objectives are to evaluate safety and tolerability.
Approved WMOCompleted
The objective of this study is to assess the technical feasibility of the EsoFLIP dilation balloon in the treatment of achalasia